Basilea Pharmaceutica
BSLN.SW
$61.48
Share price
-0.79%
Change (1 day)
30.98%
Change (1 year)
Categories
Operating Margin for Basilea Pharmaceutica (BSLN.SW)
Operating Margin at the end of 2024: 28.90%
According to Basilea Pharmaceutica's latest financial reports and stock price the company's current Operating Margin is 28.89%. At the end of 2024 the company had an Operating Margin of 28.90%.
Operating Margin history for Basilea Pharmaceutica from 2002 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 28.90% | 335.42% |
| 2023 | 6.64% | -18.97% |
| 2022 | 8.19% | -278.56% |
| 2021 | -4.59% | -60.09% |
| 2020 | -11.49% | -31% |
| 2019 | -16.66% | -29.15% |
| 2018 | -23.51% | 25.43% |
| 2017 | -18.74% | -75.73% |
| 2016 | -77.22% | -33.69% |
| 2015 | -116.46% | 19.58% |
| 2014 | -97.39% | 22.13% |
| 2013 | -79.74% | -11.13% |
| 2012 | -89.72% | 5.07% |
| 2011 | -85.40% | -191.22% |
| 2010 | 93.62% | -119.97% |
| 2009 | -468.69% | -60.9% |
| 2008 | -1,198.64% | -22.39% |
| 2007 | -1,544.39% | 30.3% |
| 2006 | -1,185.30% | 628.81% |
| 2005 | -162.64% | -99.38% |
| 2004 | -26,324.03% | 79.38% |
| 2003 | -14,674.97% | -49.15% |
| 2002 | -28,859.30% |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.